Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Hyperphosphatemia Treatment in Hemodialysis Patients
NCT03861247Phase 3Completed
- Start
- Nov 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hyperphosphatemia. Started Nov 2019; status: completed.
02
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT03861247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03861247.